Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to side-effects of treatment.
Gilead to pay $40 million to settle claims it delayed newer HIV treatment to boost profits
Gilead Sciences agreed in principle to pay $40 million to more than 2,600 people living with HIV who claimed the company boosted profits by marketing